Ivonne Schulman is a Nephrology physician affiliated with University of Miami. OpenAlex indexes 160 publications with 7,463 citations (h-index 45).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1611 NW 12th Ave
Box 016960 M851
Miami, FL 331361005
Telephone
305-585-1111Registry record last updated 1 Feb 2013.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Other
70.3%Phosphate Binder53.5%Renvela56%Sevelamer Carbonate44%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia16.8%Lanthanum Carbonate100%Part D<11 patientsCardiovascular
16.8%Calcium channel blocker16.8%Amlodipine Besylate100%Part D<11 patientsBlood & clotting
12.9%Solutions for parenteral nutrition12.9%Calcium Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2016–2018 per NIH RePORTER. The latest:
- Mesenchymal stem cell therapy for endothelial dysfunction in diabetes
University of Miami School of Medicine
FY2018$687,355R01HL134558 - Mesenchymal stem cell therapy for endothelial dysfunction in diabetes
University of Miami School of Medicine
FY2017$677,730R01HL134558 - Mesenchymal stem cell therapy for endothelial dysfunction in diabetes
University of Miami School of Medicine
FY2016$649,405R01HL134558
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- US Renal Data System 2023 Annual Data Report: Epidemiology of Kidney Disease in the United States
American Journal of Kidney Diseases
2024 - US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States
American Journal of Kidney Diseases
2023 - Readmission and Mortality After Hospitalization With Acute Kidney Injury
American Journal of Kidney Diseases
2023 - US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States
American Journal of Kidney Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”